Abstract
Botulinum toxin type A (Botox(superscript ®)) is well documented as a useful therapy for smoothening dynamic facial rhytids of the upper face. Most controlled studies have focused on the treatment of glabellar frown lines, horizontal forehead lines, and crow's feet. Reports of Botulinum toxin type A use in the inferior periorbital rhytids are few and anecdotal. We present our experience comparing intradermal and intramuscular injection with Botulinum toxin type A in inferior periorbital region for the treatment of inferior periorbital rhytids. Smoothening of inferior periorbital rhytids with opening of the palpebral aperture of lower eyelids were more obviously observed on the side receiving intradermal injection with diluted Botulinum toxin type A. However, treatment-related adverse events tended to occur more frequently with intradermal injection than intramuscular injection. As the results, we thought that intradermal injection with Botulinum toxin type A in inferior periorbital regions may provide an another choice of non-surgical treatment in periorbital rhytids.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
